FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4367308277> ?p ?o ?g. }

• W4367308277 abstract "Abstract Background: Vitamin D deficiency (VDD) is highly prevalent in the pediatric intensive care unit (ICU) and associated with worse clinical course. Trials in adult ICU demonstrate rapid restoration of vitamin D status using an enteral loading dose is safe and may improve outcomes. There have been no published trials of rapid normalization of VDD in the pediatric ICU. Methods: We conducted a multicenter placebo-controlled phase II pilot feasibility randomized clinical trial from 2016 to 2017. We randomized 67 critically ill children with VDD from ICUs in Canada, Chile and Austria using a 2:1 randomization ratio to receive a loading dose of enteral cholecalciferol (10,000 IU/kg, maximum of 400,000 IU) or placebo. Participants, care givers, and outcomes assessors were blinded. The primary objective was to determine whether the loading dose normalized vitamin D status (25(OH)D >75 nmol/L). Secondary objectives were to evaluate for adverse events and assess the feasibility of a phase III trial. Results: Of 67 randomized participants, one was withdrawn and seven received more than one dose of cholecalciferol before the protocol was amended to a single loading dose, leaving 59 participants in the primary analyses (40 treatment, 19 placebo). Thirty-one/38 (81.6%) participants in the treatment arm achieved a plasma 25(OH)D concentration >75 nmol/L versus 1/18 (5.6%) the placebo arm. The mean (SD) 25(OH)D concentration in the treatment arm was 125.9 nmol/L (63.4). There was no evidence of vitamin D toxicity and no major drug or safety protocol violations. The accrual rate was 3.4 patients/month, supporting feasibility of a larger trial. A day 7 blood sample was collected for 84% of patients. A survey administered to 40 participating families showed that health-related quality of life (HRQL) was the most important outcome for families for the main trial (30, 75%). Conclusions: A single 10,000 IU/kg dose can rapidly and safely normalize plasma 25(OH)D concentrations in critically ill children with VDD, but with significant variability in 25(OH)D concentrations. We established that a phase III multicentre trial is feasible. Using an outcome collected after hospital discharge (HRQL) will require strategies to minimize loss-to-follow-up. Trial Registration: Clinicaltrials.gov NCT02452762Registered 25/05/2015, https://clinicaltrials.gov/ct2/show/NCT02452762?term=NCT02452762&draw=2&rank=1" @default.
• W4367308277 created "2023-04-29" @default.
• W4367308277 creator A5001406504 @default.
• W4367308277 creator A5003700320 @default.
• W4367308277 creator A5004112332 @default.
• W4367308277 creator A5004669157 @default.
• W4367308277 creator A5011306424 @default.
• W4367308277 creator A5013460050 @default.
• W4367308277 creator A5015358123 @default.
• W4367308277 creator A5023037123 @default.
• W4367308277 creator A5023257162 @default.
• W4367308277 creator A5025068459 @default.
• W4367308277 creator A5038178023 @default.
• W4367308277 creator A5038634249 @default.
• W4367308277 creator A5039379467 @default.
• W4367308277 creator A5039775439 @default.
• W4367308277 creator A5054779182 @default.
• W4367308277 creator A5065187538 @default.
• W4367308277 creator A5075403632 @default.
• W4367308277 creator A5078126699 @default.
• W4367308277 creator A5080391140 @default.
• W4367308277 creator A5084706902 @default.
• W4367308277 creator A5089748758 @default.
• W4367308277 date "2023-04-28" @default.
• W4367308277 modified "2023-10-18" @default.
• W4367308277 title "A phase II dose evaluation pilot feasibility randomized controlled trial of cholecalciferol in critically ill children with vitamin D deficiency (VITdAL-PICU study)" @default.
• W4367308277 cites W1948022906 @default.
• W4367308277 cites W1959912230 @default.
• W4367308277 cites W1974347542 @default.
• W4367308277 cites W1978586171 @default.
• W4367308277 cites W1979779324 @default.
• W4367308277 cites W1994023532 @default.
• W4367308277 cites W2007025920 @default.
• W4367308277 cites W2012815084 @default.
• W4367308277 cites W2015749743 @default.
• W4367308277 cites W2020117837 @default.
• W4367308277 cites W2024012276 @default.
• W4367308277 cites W2027766207 @default.
• W4367308277 cites W2029090892 @default.
• W4367308277 cites W2029973076 @default.
• W4367308277 cites W2034260925 @default.
• W4367308277 cites W2041302995 @default.
• W4367308277 cites W2044328774 @default.
• W4367308277 cites W2069151846 @default.
• W4367308277 cites W2072019641 @default.
• W4367308277 cites W2082232385 @default.
• W4367308277 cites W2091001271 @default.
• W4367308277 cites W2096589868 @default.
• W4367308277 cites W2113042902 @default.
• W4367308277 cites W2118396099 @default.
• W4367308277 cites W2124070987 @default.
• W4367308277 cites W2125663148 @default.
• W4367308277 cites W2128177260 @default.
• W4367308277 cites W2131626713 @default.
• W4367308277 cites W2136043990 @default.
• W4367308277 cites W2138697408 @default.
• W4367308277 cites W2142779576 @default.
• W4367308277 cites W2146610462 @default.
• W4367308277 cites W2150057261 @default.
• W4367308277 cites W2160008678 @default.
• W4367308277 cites W2168688899 @default.
• W4367308277 cites W2222881185 @default.
• W4367308277 cites W2232744241 @default.
• W4367308277 cites W2254352364 @default.
• W4367308277 cites W2281981032 @default.
• W4367308277 cites W2289486397 @default.
• W4367308277 cites W2307805172 @default.
• W4367308277 cites W2321829810 @default.
• W4367308277 cites W2322919301 @default.
• W4367308277 cites W2345994200 @default.
• W4367308277 cites W2404436473 @default.
• W4367308277 cites W2443727205 @default.
• W4367308277 cites W2539148264 @default.
• W4367308277 cites W2556507193 @default.
• W4367308277 cites W2580636740 @default.
• W4367308277 cites W2733556186 @default.
• W4367308277 cites W2773741791 @default.
• W4367308277 cites W2789247665 @default.
• W4367308277 cites W2981679265 @default.
• W4367308277 cites W2983252669 @default.
• W4367308277 cites W2995672851 @default.
• W4367308277 cites W2995942269 @default.
• W4367308277 cites W3006294583 @default.
• W4367308277 cites W3023349430 @default.
• W4367308277 cites W3089181182 @default.
• W4367308277 cites W3162993738 @default.
• W4367308277 cites W3216708770 @default.
• W4367308277 cites W340047841 @default.
• W4367308277 cites W892061901 @default.
• W4367308277 doi "https://doi.org/10.21203/rs.3.rs-2743638/v1" @default.
• W4367308277 hasPublicationYear "2023" @default.
• W4367308277 type Work @default.
• W4367308277 citedByCount "0" @default.
• W4367308277 crossrefType "posted-content" @default.
• W4367308277 hasAuthorship W4367308277A5001406504 @default.
• W4367308277 hasAuthorship W4367308277A5003700320 @default.
• W4367308277 hasAuthorship W4367308277A5004112332 @default.
• W4367308277 hasAuthorship W4367308277A5004669157 @default.
• W4367308277 hasAuthorship W4367308277A5011306424 @default.
• W4367308277 hasAuthorship W4367308277A5013460050 @default.

• next